FIELD: medicine.
SUBSTANCE: invention relates to an application of a polymorphic form of trimebutine maleate for treating diseases of the gastrointestinal tract, wherein said polymorphic form on a powder X-ray diffractogram has characteristic peaks at the following angles 2θ, ° (± 0.1°): 8.7; 11.6; 13.2; 15.3; 21.5; 23.4; 27.9; 30.8. The invention also relates to an application of a pharmaceutical composition in a solid form exhibiting spasmolytic activity for treating diseases of the gastrointestinal tract, wherein said pharmaceutical composition comprises a therapeutically effective amount of the polymorphic form of trimebutine maleate with characteristic peaks on the X-ray powder diffractogram at the following angles 2θ, ° (± 0.1°): 8.7; 11.6; 13.2; 15.3; 21.5; 23.4; 27.9; 30.8, and at least one pharmaceutically acceptable carrier.
EFFECT: form of trimebutine maleate, stable in storage, non-hygroscopic, and well-soluble, intended for creating a medicinal product.
3 cl, 1 dwg, 4 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW POLYMORPHIC FORMS OF TRIMEBUTINE MALEATE, METHOD FOR PRODUCTION AND APPLICATION | 2019 |
|
RU2770300C2 |
| NOVEL POLYMORPHIC FORMS OF TRIMEBUTINE MALEATE, METHOD FOR PRODUCTION AND USE THEREOF | 2017 |
|
RU2706166C2 |
| COMBINATION FOR TREATING FUNCTIONAL GASTROINTESTINAL DISEASES | 2019 |
|
RU2733719C1 |
| POLYMORPHOUS FORMS OF ICOTINIB MALEATE AND USES THEREOF | 2014 |
|
RU2708079C2 |
| NOVEL POLYMORPHOUS FORMS OF RIFAXIMIN, SYNTHESIS METHODS AND USE THEREOF IN MEDICINAL PREPARATIONS | 2006 |
|
RU2397985C2 |
| 3-[1,2,3,6-TETRAHYDROPYRIDIN-2-YL]PYRIDINE GLUTARATE OR PHARMACEUTICALLY ACCEPTABLE SOLVATE THEREOF | 2019 |
|
RU2823979C2 |
| POLYMORPHIC FORMS OF ICOTINIB AND USES THEREOF | 2014 |
|
RU2710013C2 |
| POLYMORPH OF RIFAXIMIN AND PREPARATION METHOD THEREOF | 2012 |
|
RU2593750C2 |
| CRYSTALLINE SOLVATES OF HYDROCHLORIDE 6-(PIPERIDIN-4-YLOXY)-2H-ISOQUINOLIN-1-ONE | 2012 |
|
RU2619129C2 |
| RETARD TABLETS OF TRIMEBUTINE | 2013 |
|
RU2536254C1 |
